Research has shown that the effectiveness of anti-PD-1 therapy is determined by the expression of PD-L1 on the tumor, highlighting the importance of the PD-1/PD-L1 axis in treatment response (Steele et al., 2011). This evidence concerns the gene CD274 and neoplasm.